Clinical Trial Details

Trial ID: L0822
Source ID: IRCT2016040318124N3
Associated Drug: Melatonin
Title: Compare the therapeutic effect of Melatonin, Metformin and Vitamin E on liver function, sugar and lipid factors in patients with non-alcoholic fatty liver disease (NAFLD) dietary regimen
Acronym: --
Status: Not Recruiting
Study Results: No Results Available
Results: --
Conditions: Nonalcoholic fatty liver disease [NAFLD]. <br>Fatty (change of) liver, not elsewhere classified;Fatty (change of) liver, not elsewhere classified
Interventions: Intervention 1: Administration of melatonin (10 mg tablet) once a day with diet for a period of 3 months. Intervention 2: Administration of metformin (500 mg tablet) once a day with diet for a period of 3 months. Intervention 3: Administration of vitamin
Outcome Measures: Liver function tests. Timepoint: Before treatment and 3 months later. Method of measurement: blood sample.Lipid tests. Timepoint: Before treatment and 3 months later. Method of measurement: blood sample.;Sugar tests. Timepoint: Before treatment and 3 months later. Method of measurement: blood sample.
Sponsor/Collaborators: Vice chancellor for research, Qazvin University of Medical Sciences
Gender: All
Age: 20 years50 years
Phases: Phase 3
Enrollment: 90
Study Type: interventional
Study Designs: Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment.
Start Date: 28/04/2017
Completion Date: --
Results First Posted: --
Last Update Posted: 22 February 2018
Locations: Iran (Islamic Republic of)
URL: http://en.irct.ir/trial/16532